ReViral's Series B Round

ReViral raised a round of funding on August 01, 2018.

ReViral is an antiviral drug discovery and development company, focused on novel antiviral treatments for diseases caused by the respiratory syncytial virus (RSV).…

Articles about ReViral's Series B Round: